Sinphar Pharmaceutical Co., Ltd. (1734)
Market Closed
10 Jun, 05:30
TWSE TWSE Primary NT$
31. 30
+0.05
+0.16%
NT$
5.92B Market Cap
13.52 P/E Ratio
3.81% Div Yield
199,159 Volume
4.68 Eps
NT$ 31.25
Previous Close Want to track 1734 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sinphar Pharmaceutical Co., Ltd. (1734) Statistics
Valuation metrics
Market Cap 5.92B
Enterprise value 6.59B
Trailing P/E (ttm) 16.82
Forward P/E -
PEG ratio 4.74
Price/Sales (ttm) 1.76
Price/Book (mrq) 1.56
Enterprise Value/Revenue 1.94
Enterprise Value/EBITDA 10.25
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 447.68K
Average volume (90 days) 340.53K
Price summary
52-Week low 29.67
52-Week high 32.6
Beta -
50-Day moving average 31.14
200-Day moving average 30.92
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.95
Trailing annual dividend yield 0.0303%
5-Year annual dividend yield -
Payout ratio 0.55
Dividend Date 15 Aug 2025
Ex-Dividend Date 11 Jul 2025
Last split factor 1,050:1,000
Last split Date 2 Sep 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.1%
Operating margin 0.12%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.1%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 19.39
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.87
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.91
Total debt (mrq) -
Total Debt/Equity (mrq) 0.48
Current ratio (mrq) 2.37%
Book value per share (mrq) 21.76
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
